Answers are grounded in this paper and cite their sources.
In summary, these findings provide preclinical evidence supporting further evaluation of agents such as DMAPT and gemcitabine for the prevention and treatment of pancreatic cancer.
No takes yet. Share an insight, caveat, or question.
Yip-Schneider et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: